Compile Data Set for Download or QSAR
maximum 50k data
Found 1105 Enz. Inhib. hit(s) with Target = 'Leukotriene B4 receptor'
TargetLeukotriene B4 receptor 1(Homo sapiens (Human))
Merk Sharp & Dohme

US Patent
LigandPNGBDBM406370(N-(tert-Butylsulfonyl)-4-fluoro-2-((3S,4R or 3R,4S...)
Affinity DataEC50:  2nMAssay Description:The ability of compounds to antagonize the human BLT1 receptor was determined using a kit to measure changes in intracellular cyclic AMP levels (cAMP...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sidPDB
TargetLeukotriene B4 receptor 1(Homo sapiens (Human))
Merk Sharp & Dohme

US Patent
LigandPNGBDBM406401(US10336733, Example 45)
Affinity DataEC50:  3nMAssay Description:The ability of compounds to antagonize the human BLT1 receptor was determined using a kit to measure changes in intracellular cyclic AMP levels (cAMP...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLeukotriene B4 receptor 1(Homo sapiens (Human))
Merk Sharp & Dohme

US Patent
LigandPNGBDBM406365(4-Fluoro-2-((3S,4R or 3R,4S)-4-hydroxy-3-(pyridin-...)
Affinity DataEC50:  4nMAssay Description:The ability of compounds to antagonize the human BLT1 receptor was determined using a kit to measure changes in intracellular cyclic AMP levels (cAMP...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLeukotriene B4 receptor 1(Homo sapiens (Human))
Merk Sharp & Dohme

US Patent
LigandPNGBDBM406372(N-(Cyclopropylsulfonyl)-4-fluoro-2-((3S,4R or 3R,4...)
Affinity DataEC50:  4nMAssay Description:The ability of compounds to antagonize the human BLT1 receptor was determined using a kit to measure changes in intracellular cyclic AMP levels (cAMP...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLeukotriene B4 receptor 1(Homo sapiens (Human))
Merk Sharp & Dohme

US Patent
LigandPNGBDBM410090(N-(tert-Butylsulfonyl)-2-((rac-trans)-4-hydroxy-3-...)
Affinity DataEC50:  5nMAssay Description:The ability of compounds to antagonize the human BLT1 receptor was determined using a kit to measure changes in intracellular cyclic AMP levels (cAMP...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLeukotriene B4 receptor 1(Homo sapiens (Human))
Merk Sharp & Dohme

US Patent
LigandPNGBDBM406404(N-(tert-Butylsulfonyl)-2-((3S,4R or 3R,4S)-4-hydro...)
Affinity DataEC50:  5nMAssay Description:The ability of compounds to antagonize the human BLT1 receptor was determined using a kit to measure changes in intracellular cyclic AMP levels (cAMP...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLeukotriene B4 receptor 1(Homo sapiens (Human))
Merk Sharp & Dohme

US Patent
LigandPNGBDBM410088(US10370368, Example 5)
Affinity DataEC50:  5nMAssay Description:The ability of compounds to antagonize the human BLT1 receptor was determined using a kit to measure changes in intracellular cyclic AMP levels (cAMP...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLeukotriene B4 receptor 1(Homo sapiens (Human))
Merk Sharp & Dohme

US Patent
LigandPNGBDBM406358(4-Fluoro-2-((3S,4R or 3R,4S)-4-hydroxy-3-(pyridin-...)
Affinity DataEC50:  6nMAssay Description:The ability of compounds to antagonize the human BLT1 receptor was determined using a kit to measure changes in intracellular cyclic AMP levels (cAMP...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLeukotriene B4 receptor 1(Homo sapiens (Human))
Merk Sharp & Dohme

US Patent
LigandPNGBDBM410051(US10370368, Example 1)
Affinity DataEC50:  6nMAssay Description:The ability of compounds to antagonize the human BLT1 receptor was determined using a kit to measure changes in intracellular cyclic AMP levels (cAMP...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLeukotriene B4 receptor 1(Homo sapiens (Human))
Merk Sharp & Dohme

US Patent
LigandPNGBDBM410055(US10370368, Example 2 | US10370368, Example 3)
Affinity DataEC50:  6nMAssay Description:The ability of compounds to antagonize the human BLT1 receptor was determined using a kit to measure changes in intracellular cyclic AMP levels (cAMP...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLeukotriene B4 receptor 1(Homo sapiens (Human))
Merk Sharp & Dohme

US Patent
LigandPNGBDBM410092(N-(Cyclopropylsulfonyl)-2-((rac-trans)-4-hydroxy-3...)
Affinity DataEC50:  6nMAssay Description:The ability of compounds to antagonize the human BLT1 receptor was determined using a kit to measure changes in intracellular cyclic AMP levels (cAMP...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLeukotriene B4 receptor 1(Homo sapiens (Human))
Merk Sharp & Dohme

US Patent
LigandPNGBDBM410087(N-(tert-Butylsulfonyl)-2-((rac-trans)-4-hydroxy-3-...)
Affinity DataEC50:  8nMAssay Description:The ability of compounds to antagonize the human BLT1 receptor was determined using a kit to measure changes in intracellular cyclic AMP levels (cAMP...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLeukotriene B4 receptor 1(Homo sapiens (Human))
Merk Sharp & Dohme

US Patent
LigandPNGBDBM410092(N-(Cyclopropylsulfonyl)-2-((rac-trans)-4-hydroxy-3...)
Affinity DataEC50:  9nMAssay Description:The ability of compounds to antagonize the human BLT1 receptor was determined using a kit to measure changes in intracellular cyclic AMP levels (cAMP...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLeukotriene B4 receptor 1(Homo sapiens (Human))
Merk Sharp & Dohme

US Patent
LigandPNGBDBM406396(2-((Rac-trans)-3-([1,1′-Biphenyl]-4-ylmethyl...)
Affinity DataEC50:  9nMAssay Description:The ability of compounds to antagonize the human BLT1 receptor was determined using a kit to measure changes in intracellular cyclic AMP levels (cAMP...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLeukotriene B4 receptor 1(Homo sapiens (Human))
Merk Sharp & Dohme

US Patent
LigandPNGBDBM406388(N-(tert-Butylsulfonyl)-2-((rac-trans)-4-hydroxy-3-...)
Affinity DataEC50:  9nMAssay Description:The ability of compounds to antagonize the human BLT1 receptor was determined using a kit to measure changes in intracellular cyclic AMP levels (cAMP...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLeukotriene B4 receptor 1(Homo sapiens (Human))
Merk Sharp & Dohme

US Patent
LigandPNGBDBM406396(2-((Rac-trans)-3-([1,1′-Biphenyl]-4-ylmethyl...)
Affinity DataEC50:  11nMAssay Description:The ability of compounds to antagonize the human BLT1 receptor was determined using a kit to measure changes in intracellular cyclic AMP levels (cAMP...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLeukotriene B4 receptor 1(Homo sapiens (Human))
Merk Sharp & Dohme

US Patent
LigandPNGBDBM406388(N-(tert-Butylsulfonyl)-2-((rac-trans)-4-hydroxy-3-...)
Affinity DataEC50:  11nMAssay Description:The ability of compounds to antagonize the human BLT1 receptor was determined using a kit to measure changes in intracellular cyclic AMP levels (cAMP...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLeukotriene B4 receptor 1(Homo sapiens (Human))
Merk Sharp & Dohme

US Patent
LigandPNGBDBM410091(N-(Cyclopropylsulfonyl)-2-((rac-trans)-4-hydroxy-3...)
Affinity DataEC50:  12nMAssay Description:The ability of compounds to antagonize the human BLT1 receptor was determined using a kit to measure changes in intracellular cyclic AMP levels (cAMP...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLeukotriene B4 receptor 1(Homo sapiens (Human))
Merk Sharp & Dohme

US Patent
LigandPNGBDBM406378(2-((3S,4R or 3R,4S)-3-Benzyl-4-hydroxychroman-7-yl...)
Affinity DataEC50:  15nMAssay Description:The ability of compounds to antagonize the human BLT1 receptor was determined using a kit to measure changes in intracellular cyclic AMP levels (cAMP...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLeukotriene B4 receptor 1(Homo sapiens (Human))
Merk Sharp & Dohme

US Patent
LigandPNGBDBM406402(2-(Rac-trans)-4-Hydroxy-3-((2-phenyloxazol-4-yl)me...)
Affinity DataEC50:  15nMAssay Description:The ability of compounds to antagonize the human BLT1 receptor was determined using a kit to measure changes in intracellular cyclic AMP levels (cAMP...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLeukotriene B4 receptor 1(Homo sapiens (Human))
Merk Sharp & Dohme

US Patent
LigandPNGBDBM406381(US10336733, Example 25)
Affinity DataEC50:  16nMAssay Description:The ability of compounds to antagonize the human BLT1 receptor was determined using a kit to measure changes in intracellular cyclic AMP levels (cAMP...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLeukotriene B4 receptor 1(Homo sapiens (Human))
Merk Sharp & Dohme

US Patent
LigandPNGBDBM406368(N-(tert-Butylsulfonyl)-2-((3S,4R or 3R,4S)-4-hydro...)
Affinity DataEC50:  17nMAssay Description:The ability of compounds to antagonize the human BLT1 receptor was determined using a kit to measure changes in intracellular cyclic AMP levels (cAMP...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLeukotriene B4 receptor 1(Homo sapiens (Human))
Merk Sharp & Dohme

US Patent
LigandPNGBDBM406380(2-((3S,4R or 3R,4S)-3-Benzyl-4-hydroxychroman-7-yl...)
Affinity DataEC50:  17nMAssay Description:The ability of compounds to antagonize the human BLT1 receptor was determined using a kit to measure changes in intracellular cyclic AMP levels (cAMP...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLeukotriene B4 receptor 1(Homo sapiens (Human))
Merk Sharp & Dohme

US Patent
LigandPNGBDBM406399(US10336733, Example 43)
Affinity DataEC50:  19nMAssay Description:The ability of compounds to antagonize the human BLT1 receptor was determined using a kit to measure changes in intracellular cyclic AMP levels (cAMP...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLeukotriene B4 receptor 2(Homo sapiens (Human))
Fraunhofer Ime

Curated by ChEMBL
LigandPNGBDBM50561399(CHEMBL4761937)
Affinity DataEC50:  22nMAssay Description:Agonist activity at human BLT2 isoform 2 expressed in CHO-K1 cells over-expressing GNA14 assessed as stimulation of IP-1 accumulation incubated for 9...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetLeukotriene B4 receptor 1(Homo sapiens (Human))
Merk Sharp & Dohme

US Patent
LigandPNGBDBM406364(2-((3S,4R or 3R,4S)-4-Hydroxy-3-(pyridin-2-ylmethy...)
Affinity DataEC50:  22nMAssay Description:The ability of compounds to antagonize the human BLT1 receptor was determined using a kit to measure changes in intracellular cyclic AMP levels (cAMP...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLeukotriene B4 receptor 2(Homo sapiens (Human))
Fraunhofer Ime

Curated by ChEMBL
LigandPNGBDBM50561396(CHEMBL4789730)
Affinity DataEC50:  23nMAssay Description:Agonist activity at human BLT2 isoform 2 expressed in CHO-K1 cells over-expressing GNA14 assessed as stimulation of IP-1 accumulation incubated for 9...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetLeukotriene B4 receptor 1(Homo sapiens (Human))
Merk Sharp & Dohme

US Patent
LigandPNGBDBM406374(N-((Cyclopropylmethyl)sulfonyl)-2-((3,4-trans)-4-h...)
Affinity DataEC50:  23nMAssay Description:The ability of compounds to antagonize the human BLT1 receptor was determined using a kit to measure changes in intracellular cyclic AMP levels (cAMP...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLeukotriene B4 receptor 1(Homo sapiens (Human))
Merk Sharp & Dohme

US Patent
LigandPNGBDBM406373(2-((3,4-trans)-4-Hydroxy-3-(pyridin-2-ylmethyl)chr...)
Affinity DataEC50:  24nMAssay Description:The ability of compounds to antagonize the human BLT1 receptor was determined using a kit to measure changes in intracellular cyclic AMP levels (cAMP...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLeukotriene B4 receptor 2(Homo sapiens (Human))
Fraunhofer Ime

Curated by ChEMBL
LigandPNGBDBM50561401(CHEMBL4777675)
Affinity DataEC50:  25nMAssay Description:Agonist activity at human BLT2 isoform 2 expressed in CHO-K1 cells over-expressing GNA14 assessed as stimulation of IP-1 accumulation incubated for 9...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetLeukotriene B4 receptor 2(Homo sapiens (Human))
Fraunhofer Ime

Curated by ChEMBL
LigandPNGBDBM50561373(CHEMBL4754213)
Affinity DataEC50:  26nMAssay Description:Agonist activity at human BLT2 isoform 2 expressed in CHO-K1 cells over-expressing GNA14 assessed as stimulation of IP-1 accumulation incubated for 9...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetLeukotriene B4 receptor 1(Homo sapiens (Human))
Merk Sharp & Dohme

US Patent
LigandPNGBDBM406383(US10336733, Example 27)
Affinity DataEC50:  26nMAssay Description:The ability of compounds to antagonize the human BLT1 receptor was determined using a kit to measure changes in intracellular cyclic AMP levels (cAMP...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLeukotriene B4 receptor 2(Homo sapiens (Human))
Fraunhofer Ime

Curated by ChEMBL
LigandPNGBDBM50561372(CHEMBL4793225)
Affinity DataEC50:  27nMAssay Description:Agonist activity at human BLT2 isoform 2 expressed in CHO-K1 cells over-expressing GNA14 assessed as stimulation of IP-1 accumulation incubated for 9...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetLeukotriene B4 receptor 1(Homo sapiens (Human))
Merk Sharp & Dohme

US Patent
LigandPNGBDBM406362(N-(Cyclopropylsulfonyl)-2-((3S,4R or 3R,4S)-4-hydr...)
Affinity DataEC50:  28nMAssay Description:The ability of compounds to antagonize the human BLT1 receptor was determined using a kit to measure changes in intracellular cyclic AMP levels (cAMP...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLeukotriene B4 receptor 2(Homo sapiens (Human))
Fraunhofer Ime

Curated by ChEMBL
LigandPNGBDBM50544639(CHEMBL4637519)
Affinity DataEC50:  29nMAssay Description:Agonist activity at human BLT2 isoform 2 expressed in CHO-K1 cells over-expressing GNA14 assessed as stimulation of IP-1 accumulation incubated for 9...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetLeukotriene B4 receptor 1(Homo sapiens (Human))
Merk Sharp & Dohme

US Patent
LigandPNGBDBM406398(US10336733, Example 42)
Affinity DataEC50:  35nMAssay Description:The ability of compounds to antagonize the human BLT1 receptor was determined using a kit to measure changes in intracellular cyclic AMP levels (cAMP...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLeukotriene B4 receptor 2(Homo sapiens (Human))
Fraunhofer Ime

Curated by ChEMBL
LigandPNGBDBM50561382(CHEMBL4759277)
Affinity DataEC50:  36nMAssay Description:Agonist activity at human BLT2 isoform 2 expressed in CHO-K1 cells over-expressing GNA14 assessed as stimulation of IP-1 accumulation incubated for 9...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetLeukotriene B4 receptor 1(Homo sapiens (Human))
Merk Sharp & Dohme

US Patent
LigandPNGBDBM406392(N-(tert-Butylsulfonyl)-2-((rac-trans)-3-((1-ethyl-...)
Affinity DataEC50:  36nMAssay Description:The ability of compounds to antagonize the human BLT1 receptor was determined using a kit to measure changes in intracellular cyclic AMP levels (cAMP...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLeukotriene B4 receptor 1(Homo sapiens (Human))
Merk Sharp & Dohme

US Patent
LigandPNGBDBM406395(2-((Rac-cis)-3-([1,1′-Biphenyl]-4-ylmethyl)-...)
Affinity DataEC50:  37nMAssay Description:The ability of compounds to antagonize the human BLT1 receptor was determined using a kit to measure changes in intracellular cyclic AMP levels (cAMP...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLeukotriene B4 receptor 2(Homo sapiens (Human))
Fraunhofer Ime

Curated by ChEMBL
LigandPNGBDBM50561384(CHEMBL4742371)
Affinity DataEC50:  38nMAssay Description:Agonist activity at human BLT2 isoform 2 expressed in CHO-K1 cells over-expressing GNA14 assessed as stimulation of IP-1 accumulation incubated for 9...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetLeukotriene B4 receptor 2(Homo sapiens (Human))
Fraunhofer Ime

Curated by ChEMBL
LigandPNGBDBM50561389(CHEMBL4753057)
Affinity DataEC50:  42nMAssay Description:Agonist activity at human BLT2 isoform 2 expressed in CHO-K1 cells over-expressing GNA14 assessed as stimulation of IP-1 accumulation incubated for 9...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetLeukotriene B4 receptor 1(Homo sapiens (Human))
Merk Sharp & Dohme

US Patent
LigandPNGBDBM406376(2-((3,4-trans)-4-Hydroxy-3-(pyridin-2-ylmethyl)chr...)
Affinity DataEC50:  44nMAssay Description:The ability of compounds to antagonize the human BLT1 receptor was determined using a kit to measure changes in intracellular cyclic AMP levels (cAMP...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLeukotriene B4 receptor 2(Homo sapiens (Human))
Fraunhofer Ime

Curated by ChEMBL
LigandPNGBDBM50561376(CHEMBL4752602)
Affinity DataEC50:  48nMAssay Description:Agonist activity at human BLT2 isoform 2 expressed in CHO-K1 cells over-expressing GNA14 assessed as stimulation of IP-1 accumulation incubated for 9...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetLeukotriene B4 receptor 2(Homo sapiens (Human))
Fraunhofer Ime

Curated by ChEMBL
LigandPNGBDBM50561394(CHEMBL4781057)
Affinity DataEC50:  48nMAssay Description:Agonist activity at human BLT2 isoform 2 expressed in CHO-K1 cells over-expressing GNA14 assessed as stimulation of IP-1 accumulation incubated for 9...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetLeukotriene B4 receptor 1(Homo sapiens (Human))
Merk Sharp & Dohme

US Patent
LigandPNGBDBM406375(N-(Cyclopentylsulfonyl)-2-((3,4-trans)-4-hydroxy-3...)
Affinity DataEC50:  48nMAssay Description:The ability of compounds to antagonize the human BLT1 receptor was determined using a kit to measure changes in intracellular cyclic AMP levels (cAMP...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLeukotriene B4 receptor 2(Homo sapiens (Human))
Fraunhofer Ime

Curated by ChEMBL
LigandPNGBDBM50561365(CHEMBL4785658)
Affinity DataEC50:  48nMAssay Description:Agonist activity at human BLT2 isoform 2 expressed in CHO-K1 cells over-expressing GNA14 assessed as stimulation of IP-1 accumulation incubated for 9...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetLeukotriene B4 receptor 2(Homo sapiens (Human))
Fraunhofer Ime

Curated by ChEMBL
LigandPNGBDBM50561370(CHEMBL4755616)
Affinity DataEC50:  49nMAssay Description:Agonist activity at human BLT2 isoform 2 expressed in CHO-K1 cells over-expressing GNA14 assessed as stimulation of IP-1 accumulation incubated for 9...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetLeukotriene B4 receptor 2(Homo sapiens (Human))
Fraunhofer Ime

Curated by ChEMBL
LigandPNGBDBM50561371(CHEMBL4778464)
Affinity DataEC50:  52nMAssay Description:Agonist activity at human BLT2 isoform 2 expressed in CHO-K1 cells over-expressing GNA14 assessed as stimulation of IP-1 accumulation incubated for 9...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetLeukotriene B4 receptor 2(Homo sapiens (Human))
Fraunhofer Ime

Curated by ChEMBL
LigandPNGBDBM50561381(CHEMBL4753841)
Affinity DataEC50:  52nMAssay Description:Agonist activity at human BLT2 isoform 2 expressed in CHO-K1 cells over-expressing GNA14 assessed as stimulation of IP-1 accumulation incubated for 9...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetLeukotriene B4 receptor 1(Homo sapiens (Human))
Merk Sharp & Dohme

US Patent
LigandPNGBDBM406400(US10336733, Example 44)
Affinity DataEC50:  60nMAssay Description:The ability of compounds to antagonize the human BLT1 receptor was determined using a kit to measure changes in intracellular cyclic AMP levels (cAMP...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Displayed 1 to 50 (of 1105 total ) | Next | Last >>
Jump to: